Ferric citrate
- Generic Name
- Ferric citrate
- Brand Names
- Auryxia
- Drug Type
- Small Molecule
- Chemical Formula
- C18H32Fe4O31
- CAS Number
- -
- Unique Ingredient Identifier
- Q91187K011
- Background
Tetraferric tricitrate decahydrate is an iron containing phosphate binder used to treat hyperphosphatemia and iron deficiency anemia in adults with chronic kidney disease.
Tetraferric tricitrate decahydrate was granted FDA approval on 5 September 2014.
- Indication
Tetraferric tricitrate decahydrate is indicated to control serum phosphorous in adults with chronic kidney disease who require dialysis. Tetraferric tricitrate decahydrate is also indicated to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis.
- Associated Conditions
- Hyperphosphataemia, Iron Deficiency Anemia (IDA)
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath